While Christmas is around the corner, type 2 diabetes is there all year round, which could make the season a little challenging for those who suffer from it. But, including a certain kind of food over the holiday meals can help lower blood sugar.
The holidays also mean people can feel like eating a lot more than usual, with the promises of weight loss come the new year. However, this is not an exception for type 2 diabetics. Fortunately, potatoes have been shown to potentially lower a person’s blood sugar levels, as reported by Express. While potatoes are considered an acceptable type of food for type 2 diabetics, there are certain potatoes that have a high glycemic index, meaning it can spike blood sugar levels rather than keep it at a normal level.
But they are also low in calories and contain carbohydrates, which is what the body needs for energy. It is best advised to control the portion sizes, especially over the Christmas holiday.
To be specific, sweet potatoes and yams are the recommended types of potatoes to have in the diet. This is due to them having a low to the medium glycemic index. Sweet potatoes and yams are also low in calories and low in fat, and the skin on these sweet potatoes and yams also contain fiber, which is also beneficial for the body.
Aside from incorporating sweet potatoes and yams for Christmas (or everyday) meals, it is also important to be mindful of the servings of food as well as the intake of alcohol. Type 2 diabetics should reduce their alcohol intake over the holidays as well.
Meanwhile, for those who suffer from high blood pressure, Express previously reported limiting eating this kind of food over the holidays. Reducing the intake of cheese can help keep blood pressure levels normal. This is because despite cheese being a good source of calcium and protein, certain types of cheeses are high on saturated fat and salt.
It is advised to reduce the intake of salty cheeses such as certain kinds of feta, halloumi, Roquefort, and the cheese singles sold in groceries. Instead, opt for more low-fat and low-salt options like mozzarella, cottage cheese, and low-fat and low-salt types of feta.


Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Novo Nordisk Appoints Greg Miley as Global Head of Corporate Affairs Amid U.S. Pricing Pressure
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 



